Non-communicable diseases and external causes of death are major contributors to the risk of mortality in people with OCD

Researchers investigated the risk of cause-specific and all-cause mortality in Swedish individuals with obsessive-compulsive disorder (OCD) as compared to matched unaffected individuals or siblings.

HitGen and SGC enter drug discovery partnership

HitGen’s OpenDEL platform can be used for running affinity screening experiments against protein targets. Credit: Gorodenkoff/Shutterstock.com. Chinese company HitGen and the Structural Genomics Consortium (SGC)

September 29, 2023

UQ research finds molecular doorways to help deliver drugs into the brain

A University of Queensland researcher has found molecular doorways that could be used to help deliver drugs into the brain to treat neurological disorders.

May 2, 2024

Cancer therapies for young adults: The need for tailored treatment and diversity – Pharmaceutical Technology

Increasing diversity in clinical trials offers a key route towards helping biomanufacturers optimise oncology treatments for younger patients. Credit: Viacheslav Lopatin / Shutterstock. Cancer, once

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.